CLS-LOGO-New2021.jpg
CLS Americas and HALO Precision Diagnostics Announce 25 Patient Post-Market Study to Evaluate CLS’s TRANBERG Thermal Therapy System
February 08, 2023 12:25 ET | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and INDIAN WELLS, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems...
CLS-LOGO-New2021.jpg
CLS Americas and URN Announce Treatment of 20th & Final Patient in Clinical Study “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer”
January 31, 2023 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and MIAMI, Jan. 31, 2023 (GLOBE NEWSWIRE) -- CLS Americas, a leading provider of office-based, focal laser ablation systems in the US urology market, today announced the full twenty...
CLS Americas Exhibits TRANBERG Fusion-Guided Focal Laser Ablation Solution at Western Section AUA Meeting
November 01, 2022 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
KAUAI, Hawaii, Nov. 01, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced it will exhibit its TRANBERG™ Thermal Therapy System at the 98th...
CLS-LOGO-New2021.jpg
CLS Americas & Focalyx Present Integrated Fusion-Guided Focal Laser Ablation Solution at FOCAL 2022 Conference
September 23, 2022 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
LOS ANGELES, Sept. 23, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, and Focalyx Technologies, developer of image-guided fusion target devices, today...
CLS-LOGO-New2021.jpg
CLS Americas Debuts Office-Based, Fusion-Guided TRANBERG Focal Laser Ablation System at AUA 2022 Conference
May 12, 2022 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced it will debut its Office-Based, MR/US Fusion-Guided, TRANBERG®...
CLS-LOGO-New2021.jpg
CLS Americas and URN Announce Clinical Study “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer”
March 29, 2022 08:00 ET | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and MIAMI, March 29, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced the company’s TRANBERG® Thermal Therapy System will be used...
CLS-LOGO-New2021.jpg
CLS Americas Debuts MRI-US Fusion-Guided Focal Laser Ablation System at 97th Annual WSAUA Conference
November 02, 2021 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
Company Goal to Enable Minimally-Invasive, Focal Therapy Procedure to be Performed in an Office Setting or Clinic under Local Anesthetic INDIAN WELLS, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) --...
CLS-Logo-1.jpg
CLS Americas Targets MRI-US Fusion-Guided Focal Laser Ablation of Prostate Tumors
October 25, 2021 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced that a...
CLS-Logo-1.jpg
CLS Targets MRI-US Fusion-Guided Focal Laser Ablation of Prostate Tumors
October 25, 2021 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced that a...
CLS-Logo-1.jpg
CLS Exhibits High Precision, Image-Guided Focal Laser Ablation System at the 73rd Congress of the German Society for Urology Conference
September 14, 2021 03:00 ET | Clinical Laserthermia Systems Americas, Inc.
STUTTGART, Germany, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will present its high precision, image-guided TRANBERG® Laser Thermal Therapy...